2024 Fall Conference | C22 - Clinical Trials Update

Date Saturday 10/26/24

Time 03:00 PM - 04:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Moderator(s) Marcelo Matiello, MD, FAAN

Topic(s) General Neurology

Learning Objectives During this session, three speakers will each focus on the latest developments of interest to the clinician that have occurred in a specific subspecialty topic.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Teaching Styles Didactic

Program Materials

Event Timeline
03:00 PM - 03:30 PM PDT	Speaker	The Current State of Long-COVID: Clinical Trials and Ethical Aspects Avindra Nath, MD, MBBS, FAAN
03:30 PM - 04:00 PM PDT	Speaker	Gene Transfer Therapy: Is it Safe? Julie A. Parsons, MD
04:00 PM - 04:30 PM PDT	Speaker	Migraine Management in Special Populations Eric Kaiser, MD, PhD

Faculty Disclosures
Avindra Nath, MD, MBBS, FAAN	Dr. Nath has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from ALS Association. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Eric Kaiser, MD, PhD	The institution of Dr. Kaiser has received research support from Amgen. Dr. Kaiser has received intellectual property interests from a discovery or technology relating to health care.
Julie A. Parsons, MD	Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
Marcelo Matiello, MD, FAAN	Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.